Cardiobacterium hominis
Cardiobacterium hominis is a Gram-negative, rod-shaped bacterium that is commonly found in the human mouth. It is a member of the HACEK group, a group of bacteria that are a rare cause of infective endocarditis, an infection of the heart valves.
Characteristics[edit]
Cardiobacterium hominis is a catalase-negative and oxidase-positive bacterium. It is also fermentative, and can ferment carbohydrates. The bacterium is usually susceptible to antibiotics, including penicillin and ampicillin.
Pathogenesis[edit]
Cardiobacterium hominis is one of the bacteria that can cause infective endocarditis, a serious infection of the heart valves. This typically occurs in individuals who have pre-existing heart conditions. The bacteria can enter the bloodstream through the mouth, often as a result of dental procedures or poor oral hygiene. Once in the bloodstream, the bacteria can attach to damaged heart valves and start to multiply, leading to infective endocarditis.
Diagnosis and Treatment[edit]
Diagnosis of an infection caused by Cardiobacterium hominis is typically made by blood culture, as the bacteria can be found in the bloodstream of infected individuals. Treatment usually involves antibiotics, often given intravenously. In severe cases, surgery may be required to repair or replace damaged heart valves.
Epidemiology[edit]
Infections caused by Cardiobacterium hominis are rare. They are most commonly seen in individuals with pre-existing heart conditions, particularly those with damaged heart valves. The bacteria are part of the normal flora of the mouth, and are therefore more likely to cause infection in individuals with poor oral hygiene or who undergo dental procedures.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian